Skip to content
Riskpilot
← Back to search
Sign in
Get full access
InDex Diagnostics AB
AB
In liquidation
Org 5566022751
Stockholm
Research and experimental development on biotechnology
·
NACE 7211
Est. 2000 · 25 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on biotechnology
/
InDex Diagnostics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
BM
Bo Magnus Lagerberg
Chief Auditor
Chief Auditor
2020
KS
Karl Sten Mathias Winge
Liquidator
Liquidator
2024
Former (2)
JS
Jenny Sundqvist
Chief Executive Officer
Chief Executive Officer
2020 – 2024
CJ
Carl Johan Giléus
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2022 – 2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (4)
SL
Stig Lennart Hansson
Board of Directors
Board of Directors
2020 – 2024
PH
Peter Hakim Zerhouni
Chairman
Chairman
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
InDex Pharmaceuticals AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on InDex Diagnostics AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
2022 – 2022
WN
Wenche Nelly A Rolfsen Sandsborg
Chairman
Chairman
2020 – 2024
PH
Pernilla Helena Sandwall
Board of Directors
Board of Directors
2022 – 2022
